|
|
||||||||
,


* Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115;
Pulmonary and Critical Care Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02115;
Clinica di Malattie dellApparato Respiratorio, Dipartimento Integrato di Oncologia ed Ematologia, Università degli Studi di Modena e Reggio Emilia, Modena, Italy;
Department of Family and Preventive Medicine, University of California San Diego, CA 92101;
¶ Department of Medicine, University of California San Diego, CA 92101;
|| Department of Medical Biochemistry and Molecular Biology, Biocenter Oulu, University of Oulu, Oulu, Finland; and
# Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
The class A scavenger receptors (SR-A) MARCO and SR-AI/II are expressed on lung macrophages (M
s) and dendritic cells (DCs) and function in innate defenses against inhaled pathogens and particles. Increased expression of SR-As in the lungs of mice in an OVA-asthma model suggested an additional role in modulating responses to an inhaled allergen. After OVA sensitization and aerosol challenge, SR-AI/II and MARCO-deficient mice exhibited greater eosinophilic airway inflammation and airway hyperresponsiveness compared with wild-type mice. A role for simple SR-A-mediated Ag clearance ("scavenging") by lung M
s was excluded by the observation of a comparable uptake of fluorescent OVA by wild-type and SR-A-deficient lung M
s and DCs. In contrast, airway instillation of fluorescent Ag revealed a significantly higher traffic of labeled DCs to thoracic lymph nodes in SR-A-deficient mice than in controls. The increased migration of SR-A-deficient DCs was accompanied by the enhanced proliferation in thoracic lymph nodes of adoptively transferred OVA-specific T cells after airway OVA challenge. The data identify a novel role for SR-As expressed on lung DCs in the down-regulation of specific immune responses to aeroallergens by the reduction of DC migration from the site of Ag uptake to the draining lymph nodes.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grants ES0002 and ES11008, and by Department of Defense Grant W81XWH-06-1-0289. M.S.A. is a recipient of the Jere Mead fellowship.
2 Current address: Beth Israel Deaconess Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, HIM-1039, Boston, MA 02115.
3 M.S.A. and F.F. contributed equally to this work.
4 Address correspondence and reprint requests to Dr. Lester Kobzik, Department of Environmental Health, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. E-mail address: lkobzik{at}hsph.harvard.edu
5 Abbreviations used in this paper: SR, scavenger receptor; SR-AI/II, SR class A, type I and type II; AHR, airway hyperresponsiveness; AM, alveolar macrophage; BAL, bronchoalveolar lavage; BALF, BAL fluid; Ct, threshold cycle; C3H, C3H/HeJ; DC, dendritic cell; i.t., intratracheal; KO, knockout; LN, lymph node; MARCO, macrophage receptor with collagenous structure; M
, macrophage; Penh, enhanced pause; WT, wild type.
This article has been cited by other articles:
![]() |
K. Nakagome, K. Okunishi, M. Imamura, H. Harada, T. Matsumoto, R. Tanaka, J.-i. Miyazaki, K. Yamamoto, and M. Dohi IFN-{gamma} Attenuates Antigen-Induced Overall Immune Response in the Airway As a Th1-Type Immune Regulatory Cytokine J. Immunol., July 1, 2009; 183(1): 209 - 220. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |